フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Bausch + Lomb Provides Leadership Update PR Newswire VAUGHAN, ON, July 20, 2022 VAUGHAN, ON, July 20, 2022...
Salix Announces 2022 Gastrointestinal Health Scholars Program Winners PR Newswire LAVAL, QC, July 13, 2022 For...
Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of Directors PR...
Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation PR Newswire LAVAL, QC, June...
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™...
Bausch Health Provides Update on Solta Medical PR Newswire LAVAL, QB, June 16, 2022 LAVAL, QB, June 16, 2022...
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022 PR Newswire LAVAL, Quebec, May 18...
Bausch Health Announces Participation In Upcoming Investor Conferences PR Newswire LAVAL, QC, May 11, 2022...
Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And...
Bausch Health Companies Inc. Announces First-Quarter 2022 Results PR Newswire LAVAL, QC, May 10, 2022...
Bausch Health Announces Thomas J. Appio As Chief Executive Officer PR Newswire LAVAL, QC, May 6, 2022 LAVAL...
Bausch + Lomb Corporation Announces Pricing of IPO PR Newswire LAVAL, QC and VAUGHAN, ON, May 5, 2022 LAVAL...
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03...
Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10 PR Newswire LAVAL...
Bausch + Lomb Corporation Announces Launch of IPO and Roadshow PR Newswire LAVAL, QC and VAUGHAN, ON, April...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す